Benzinga | Aug 16, 2021 04:16PM EDT

Eton Pharmaceuticals Q2 EPS $(0.08) Beats $(0.14) Estimate, Sales $3.07M Miss $3.81M Estimate

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.14) by 42.86 percent. This is a 65.22 percent increase over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $3.07 million which missed the analyst consensus estimate of $3.81 million by 19.50 percent. This is a 15.24K percent increase over sales of $20.00 thousand the same period last year.